Drinking sugar-sweetened beverages may increase your risk of heart disease. These drinks are easy to overconsume, and they ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

Discover how the experimental drug lepodisiran dramatically lowers lipoprotein(a) levels, potentially transforming treatment ...

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

A research team has uncovered higher rates of heart disease and worse heart health affecting adults living in rural ...

Eli Lilly And Co (NYSE:LLY), on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small ...

High blood pressure increases the risk of developing metabolic syndrome, a group of health conditions that can lead to heart ...

Eli Lilly (NYSE:LLY) experienced a 6% increase in price over the last quarter, coinciding with several major developments.

Discover the key information about cardiovascular disease in Black men, including risk factors, prevention strategies, and ...

Diet and exercise have long been recognized as key contributors to a healthy heart, but how much of our heart health is ...

This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...